<DOC>
	<DOCNO>NCT02942173</DOCNO>
	<brief_summary>The purpose prospective randomize study determine whether infusion T-memory cell prevent infection child leukemia allogeneic alpha , beta T-cell receptor ( TcRab ) /CD19-depleted hematopoietic stem cell transplantation ( HSCT ) .</brief_summary>
	<brief_title>CD45RA Depleted T-cell Infusion Prevention Infections After TCRab/CD19-depleted Allo-HSCT</brief_title>
	<detailed_description>Graft-versus-host disease ( GVHD ) remain important direct complication hematopoietic stem cell transplantation . Methods use prevent GVHD include diverse pharmacologic intervention ex vivo method T-cell depletion , latter effective one . Historically depletion T-cells graft associate increased rate graft failure , relapse malignant disease prolong immune deficiency . Selective depletion TCR-alpha/beta T-lymphocytes new method hematopoietic stem cell graft manipulation , think conserve important cell population , e.g . NK cell gamma/delta T cell within graft . Preliminary result suggest TCR alpha/beta depletion ensure high engraftment rate , low early mortality good control GVHD . The problem delay immune reconstitution life-threatening viral infection remain incompletely resolve . Depletion naive ( CD45RA-positive ) T-cells develop new method graft manipulation prevent GVHD . Research data indicate alloreactivity associate mainly naive T-cell fraction . In vitro depletion CD45RA lower significantly alloreactive response retain reactivity pathogen . In previous pilot protocol investigator confirm infusion TCR-alpha/beta deplete transplantation low dose CD45RA-depleted mononuclear cell safe potentially protective viral infection . The biologic readout protocol quantitative assessment T-cell reactivity common pathogens infusion owe trial result expansion CMV-specific CD8 T-cells discover patient . In current randomize protocol investigator pose question donor lymphocytes infusion ( DLI ) low dose CD45RA-depleted mononuclear cell effective viral prophylaxis TCR-alpha/beta deplete transplantation .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Opportunistic Infections</mesh_term>
	<criteria>Patients consider candidate allogeneic hematopoietic stem cell transplantation one follow diagnosis : Acute lymphocytic leukemia ( ALL ) Acute myeloid leukemia Acute biphenotypic leukemia Acute bilinear leukemia Lymphoma Myelodysplastic syndrome Chronic myeloid leukemia Transplant processing : TCR ab/CD19depletion Donors : HLAmatch unrelated volunteer Partly haploidentical relative ALL patient remission Patients uncontrolled infection Clearance creatinine &lt; 70 ml/min Cardiac ejection fraction &lt; 40 % Patients perform pulmonary function test exclude diffuse capacity lung carbon monoxide ( DLCO ) ( correct hemoglobin ) &lt; 50 % predict ; patient unable perform pulmonary function test exclude oxygen ( O2 ) saturation &lt; 92 % room air Patients liver function test ( LFTs ) ( include total bilirubin , aspartate aminotransferase [ AST ] alanine aminotransferase [ ALT ] ) &gt; = twice upper limit normal Mental disease patient , patient 's tutor ( patient age 18 ) donor , hinder understand main point study keep treatment plan , hygiene sanitation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>CD45RA-depletion</keyword>
	<keyword>TCR-alpha/beta depletion</keyword>
	<keyword>Hematopoietic Stem Cell Transplantation</keyword>
</DOC>